We utilised a transgenic mouse model of human RyR2-R420Q (R420Q) CPVT mutation and a range of electrical and optical mapping technologies to examine the role of DAD-induced conduction abnormalities. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.